Clinical Trial Update: A Study of Atezolizumab With or Without Tiragolumab Following Neoadjuvant Chemoradiotherapy in Participants With Locally Advanced Rectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 study evaluating atezolizumab with or without tiragolumab after neoadjuvant chemoradiotherapy in locally advanced rectal cancer; currently listed as act…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• Atezolizumab (atezolizumab)
• Tiragolumab (tiragolumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Rectal Neoplasms, Rectal Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING